COVID-19

Showing NaN - NaN of 31

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in Worldwide (Placebo, Remdesivir, Baricitinib)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +70 more
Mar 9, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

COVID-19 Trial in Russian Federation, United States (Placebo, Ruxolitinib)

Terminated
  • COVID-19
  • Scottsdale, Arizona
  • +35 more
Jan 14, 2022

COVID-19 Trial in Worldwide (RDV, Placebo to Match RDV)

Terminated
  • COVID-19
  • RDV
  • Placebo to Match RDV
  • Chandler, Arizona
  • +103 more
Nov 4, 2021

COVID-19 Trial in United Kingdom, United States (Rivaroxaban, Placebo)

Terminated
  • COVID-19
  • Rogers, Arkansas
  • +19 more
Oct 20, 2021

COVID-19, Viral Respiratory Illnesses Trial in United States (Nitazoxanide, Placebo, Vitamin Super B-Complex)

Unknown status
  • COVID-19
  • Viral Respiratory Illnesses
  • Hot Springs, Arkansas
  • +25 more
Feb 5, 2021